Percutaneous lung tumor ablation

Yun Robert Sheu, Kelvin Hong

Research output: Contribution to journalArticle

Abstract

Percutaneous thermal ablation is a minimally invasive treatment for primary or secondary malignancies of the lung. Currently, 3 different modalities are available: radiofrequency, microwave, and cryoablation. Radiofrequency ablation remains to date the most developed although the other 2 modalities have their own distinct advantages. Percutaneous ablation can be used for treatment of stage 1 and 2 non-small cell lung carcinoma either alone or in combination with other therapies. Specifically, their noninvasive nature allows them to be used on patients who are otherwise deemed nonoperable. Percutaneous ablation can also be used to treat stage 3a non-small cell lung carcinoma in carefully selected patients. With nonlung primaries, percutaneous ablation can be used to control limited pulmonary metastasis, recurrences after alternative treatments, or to provide pain relief. Although the long-term data for percutaneous ablation is still being investigated, their noninvasive nature and efficacy will ensure their viability and evolution in the future. In this article we review the indications for percutaneous ablation, evaluation of the potential patient, an overview of the ablation options currently available, procedural details, potential complications, and expected results and follow-up.

Original languageEnglish (US)
Pages (from-to)239-252
Number of pages14
JournalTechniques in Vascular and Interventional Radiology
Volume16
Issue number4
DOIs
StatePublished - Dec 2013

Fingerprint

Lung
Non-Small Cell Lung Carcinoma
Neoplasms
Cryosurgery
Therapeutics
Microwaves
Hot Temperature
Neoplasm Metastasis
Recurrence
Pain

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine

Cite this

Percutaneous lung tumor ablation. / Robert Sheu, Yun; Hong, Kelvin.

In: Techniques in Vascular and Interventional Radiology, Vol. 16, No. 4, 12.2013, p. 239-252.

Research output: Contribution to journalArticle

@article{ca16731fda4c4ff0a0925a2e2b4a3be0,
title = "Percutaneous lung tumor ablation",
abstract = "Percutaneous thermal ablation is a minimally invasive treatment for primary or secondary malignancies of the lung. Currently, 3 different modalities are available: radiofrequency, microwave, and cryoablation. Radiofrequency ablation remains to date the most developed although the other 2 modalities have their own distinct advantages. Percutaneous ablation can be used for treatment of stage 1 and 2 non-small cell lung carcinoma either alone or in combination with other therapies. Specifically, their noninvasive nature allows them to be used on patients who are otherwise deemed nonoperable. Percutaneous ablation can also be used to treat stage 3a non-small cell lung carcinoma in carefully selected patients. With nonlung primaries, percutaneous ablation can be used to control limited pulmonary metastasis, recurrences after alternative treatments, or to provide pain relief. Although the long-term data for percutaneous ablation is still being investigated, their noninvasive nature and efficacy will ensure their viability and evolution in the future. In this article we review the indications for percutaneous ablation, evaluation of the potential patient, an overview of the ablation options currently available, procedural details, potential complications, and expected results and follow-up.",
author = "{Robert Sheu}, Yun and Kelvin Hong",
year = "2013",
month = "12",
doi = "10.1053/j.tvir.2013.09.001",
language = "English (US)",
volume = "16",
pages = "239--252",
journal = "Techniques in Vascular and Interventional Radiology",
issn = "1089-2516",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Percutaneous lung tumor ablation

AU - Robert Sheu, Yun

AU - Hong, Kelvin

PY - 2013/12

Y1 - 2013/12

N2 - Percutaneous thermal ablation is a minimally invasive treatment for primary or secondary malignancies of the lung. Currently, 3 different modalities are available: radiofrequency, microwave, and cryoablation. Radiofrequency ablation remains to date the most developed although the other 2 modalities have their own distinct advantages. Percutaneous ablation can be used for treatment of stage 1 and 2 non-small cell lung carcinoma either alone or in combination with other therapies. Specifically, their noninvasive nature allows them to be used on patients who are otherwise deemed nonoperable. Percutaneous ablation can also be used to treat stage 3a non-small cell lung carcinoma in carefully selected patients. With nonlung primaries, percutaneous ablation can be used to control limited pulmonary metastasis, recurrences after alternative treatments, or to provide pain relief. Although the long-term data for percutaneous ablation is still being investigated, their noninvasive nature and efficacy will ensure their viability and evolution in the future. In this article we review the indications for percutaneous ablation, evaluation of the potential patient, an overview of the ablation options currently available, procedural details, potential complications, and expected results and follow-up.

AB - Percutaneous thermal ablation is a minimally invasive treatment for primary or secondary malignancies of the lung. Currently, 3 different modalities are available: radiofrequency, microwave, and cryoablation. Radiofrequency ablation remains to date the most developed although the other 2 modalities have their own distinct advantages. Percutaneous ablation can be used for treatment of stage 1 and 2 non-small cell lung carcinoma either alone or in combination with other therapies. Specifically, their noninvasive nature allows them to be used on patients who are otherwise deemed nonoperable. Percutaneous ablation can also be used to treat stage 3a non-small cell lung carcinoma in carefully selected patients. With nonlung primaries, percutaneous ablation can be used to control limited pulmonary metastasis, recurrences after alternative treatments, or to provide pain relief. Although the long-term data for percutaneous ablation is still being investigated, their noninvasive nature and efficacy will ensure their viability and evolution in the future. In this article we review the indications for percutaneous ablation, evaluation of the potential patient, an overview of the ablation options currently available, procedural details, potential complications, and expected results and follow-up.

UR - http://www.scopus.com/inward/record.url?scp=84887604721&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84887604721&partnerID=8YFLogxK

U2 - 10.1053/j.tvir.2013.09.001

DO - 10.1053/j.tvir.2013.09.001

M3 - Article

C2 - 24238379

AN - SCOPUS:84887604721

VL - 16

SP - 239

EP - 252

JO - Techniques in Vascular and Interventional Radiology

JF - Techniques in Vascular and Interventional Radiology

SN - 1089-2516

IS - 4

ER -